Ngā hua rapu kaituhi

1

Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2 mā William R. Martin, Feixiong Cheng

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes mā Feixiong Cheng, Junfei Zhao, Zhongming Zhao

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy mā Feixiong Cheng, Peilin Jia, Quan Wang, Zhongming Zhao

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

ccmGDB: a database for cancer cell metabolism genes mā Pora Kim, Feixiong Cheng, Junfei Zhao, Zhongming Zhao

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes mā Feixiong Cheng, Junfei Zhao, Michaela Fooksa, Zhongming Zhao

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach mā Feixiong Cheng, Chuang Liu, Bairong Shen, Zhongming Zhao

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Precision medicine review: rare driver mutations and their biophysical classification mā Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers mā Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors mā Sara Akhavanfard, Roshan Padmanabhan, Lamis Yehia, Feixiong Cheng, Charis Eng

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach mā Junfei Zhao, Feixiong Cheng, Yuanyuan Wang, Carlos L. Arteaga, Zhongming Zhao

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health mā Feixiong Cheng, Han Liang, Atul J. Butte, Charis Eng, Ruth Nussinov

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer mā Iris Nira Smith, Stetson Thacker, Marilyn Seyfi, Feixiong Cheng, Charis Eng

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

A new precision medicine initiative at the dawn of exascale computing mā Ruth Nussinov, Hyunbum Jang, Guy Nir, Chung‐Jung Tsai, Feixiong Cheng

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology mā Jie Li, Zengrui Wu, Feixiong Cheng, Weihua Li, Guixia Liu, Yun Tang

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Systematic dissection of dysregulated transcription factor–miRNA feed-forward loops across tumor types mā Wei Jiang, Ramkrishna Mitra, Chen-Ching Lin, Quan Wang, Feixiong Cheng, Zhongming Zhao

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Studying Tumorigenesis through Network Evolution and Somatic Mutational Perturbations in the Cancer Interactome mā Feixiong Cheng, Peilin Jia, Quan Wang, Chen-Ching Lin, Wen‐Hsiung Li, Zhongming Zhao

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis mā Feixiong Cheng, James L. Murray, Junfei Zhao, Jinsong Sheng, Zhongming Zhao, Donald H. Rubin

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Entropy-based consensus clustering for patient stratification mā Hongfu Liu, Rui Zhao, Hong-Sheng Fang, Feixiong Cheng, Yun Fu, Yang‐Yu Liu

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Alzheimer's disease drug development pipeline: 2023 mā Jeffrey L. Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Ramón Fonseca Cacho, Feixiong Cheng

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

Alzheimer's disease drug development pipeline: 2024 mā Jeffrey L. Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Ramón Fonseca Cacho, Feixiong Cheng

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Feixiong Cheng

Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2 mā William R. Martin, Feixiong Cheng

Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes mā Feixiong Cheng, Junfei Zhao, Zhongming Zhao

Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy mā Feixiong Cheng, Peilin Jia, Quan Wang, Zhongming Zhao

ccmGDB: a database for cancer cell metabolism genes mā Pora Kim, Feixiong Cheng, Junfei Zhao, Zhongming Zhao

A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes mā Feixiong Cheng, Junfei Zhao, Michaela Fooksa, Zhongming Zhao

Investigating cellular network heterogeneity and modularity in cancer: a network entropy and unbalanced motif approach mā Feixiong Cheng, Chuang Liu, Bairong Shen, Zhongming Zhao

Precision medicine review: rare driver mutations and their biophysical classification mā Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers mā Ruth Nussinov, Hyunbum Jang, Chung‐Jung Tsai, Feixiong Cheng

Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors mā Sara Akhavanfard, Roshan Padmanabhan, Lamis Yehia, Feixiong Cheng, Charis Eng

Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach mā Junfei Zhao, Feixiong Cheng, Yuanyuan Wang, Carlos L. Arteaga, Zhongming Zhao

Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health mā Feixiong Cheng, Han Liang, Atul J. Butte, Charis Eng, Ruth Nussinov

Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer mā Iris Nira Smith, Stetson Thacker, Marilyn Seyfi, Feixiong Cheng, Charis Eng

A new precision medicine initiative at the dawn of exascale computing mā Ruth Nussinov, Hyunbum Jang, Guy Nir, Chung‐Jung Tsai, Feixiong Cheng

Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology mā Jie Li, Zengrui Wu, Feixiong Cheng, Weihua Li, Guixia Liu, Yun Tang

Systematic dissection of dysregulated transcription factor–miRNA feed-forward loops across tumor types mā Wei Jiang, Ramkrishna Mitra, Chen-Ching Lin, Quan Wang, Feixiong Cheng, Zhongming Zhao

Studying Tumorigenesis through Network Evolution and Somatic Mutational Perturbations in the Cancer Interactome mā Feixiong Cheng, Peilin Jia, Quan Wang, Chen-Ching Lin, Wen‐Hsiung Li, Zhongming Zhao

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis mā Feixiong Cheng, James L. Murray, Junfei Zhao, Jinsong Sheng, Zhongming Zhao, Donald H. Rubin

Entropy-based consensus clustering for patient stratification mā Hongfu Liu, Rui Zhao, Hong-Sheng Fang, Feixiong Cheng, Yun Fu, Yang‐Yu Liu

Alzheimer's disease drug development pipeline: 2023 mā Jeffrey L. Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Ramón Fonseca Cacho, Feixiong Cheng

Alzheimer's disease drug development pipeline: 2024 mā Jeffrey L. Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Ramón Fonseca Cacho, Feixiong Cheng

Ngā utauta rapu:

Ngā marau whai pānga